Trademark applications and grants for Cv Therapeutics Inc. Cv Therapeutics Inc has 12 trademark applications. The latest application filed is for "CARDIOVASCULAR DISEASE COMPENDIUM"
Patent Application | Date |
---|---|
Method of Identifying Partial Agonists of the A2A Receptor 20090317331 - 12/435176 Belardinelli; Luiz ;   et al. | 2009-12-24 |
Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods 20090081120 - 12/163099 Lieu; Hsiao ;   et al. | 2009-03-26 |
Myocardial Perfusion Imaging 20080267861 - 11/969047 Lieu; Hsiao D. ;   et al. | 2008-10-30 |
Methods and Compositions for Increasing Patent Tolerability During Myocardial Imaging Methods 20080213165 - 11/848743 Lieu; Hsiao ;   et al. | 2008-09-04 |
Methods for Myocardial Imaging in Patients Having a History of Pulmonary Disease 20080170990 - 11/864437 Lieu; Hsiao D. ;   et al. | 2008-07-17 |
NCAGE Code | 4EN55 | CV THERAPEUTICS INC. |
CAGE Code | 4EN55 | CV THERAPEUTICS, INC. |
DUNS | 796248110 | CV THERAPEUTICS, INC. |
SEC | 0000921506 | CV THERAPEUTICS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.